Back to All Events

2026 Best of ASCO® Honolulu


  • ‘Alohilani Resort Waikiki Beach 2490 Kalākaua Avenue Honolulu, HI, 96815 United States (map)

In-Person Access Only | 8.75 CME Credits & MOC Points

Please read:All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

Total Health's 2026 Best of ASCO® Honolulu Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.

 

Program Chairs:
Teruo Yamauchi, MD (University of Hawai’i Cancer Center)
Naoto Ueno, MD, PhD (University of Hawai’i Cancer Center)

Conference Agenda
Saturday, June 27, 2026

8:00 AM
Coffee and Exhibits

8:30 AM
Program Chair Welcome
Teruo Yamauchi, MD | University of Hawai'i Cancer Center (Program Chair)

Naoto Ueno, MD, PhD | University of Hawai'i Cancer Center (Program Chair)
Ryon Nakasone, MD, MBA, FACP | Hawai’i Society of Clinical Oncology (Program Chair)

8:40 AM
Non-Colorectal Cancer
Elizabeth Nakasone, MD | University of Hawai'i Cancer Center

9:10 AM
Colorectal Cancer
Thierry Alcindor, MD, MSc | Dana-Farber Cancer Institute

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Gilead - Offering an ADC Treatment for Patients With Pretreated HR+/HER2- mBC and mTNBC
Chelsea Gawryletz, DO | UCHealth Cancer Care and Hematology Clinic

10:40 AM
Prostate Cancer
Pedro Barata, MD | University Hospitals

11:10 AM
Non-Prostate Cancer
Mehmet Asim Bilen, MD | Winship Cancer Institute of Emory University

11:40 AM
Lunch and Exhibits

11:55 AM
Non-CME Lunch - Incyte‍ - Polycythemia Vera and Myelofibrosis | Identifying When to Intervene With JAKAFI®/JAKAFI XRTM (ruxolitinib)
Solomon Hamburg, MD | UCLA Health

12:40 PM
Housekeeping and Survey

12:50 PM
Local Clinical Trials

Ryon Nakasone, MD, MBA, FACP | Hawai’i Society of Clinical Oncology (Program Chair)
Jared Acoba, MD | University of Hawai'i Cancer Center
Stephanie Si Lim, MD, MBA | University of Hawai'i Cancer Center
Craig Boddy, MD | Hawai'i Pacific Health

1:30 PM
Leukemia
Stephanie Si Lim, MD, MBA | University of Hawai'i Cancer Center

2:00 PM
Lymphoma‍ ‍
Craig Boddy, MD | Hawai'i Pacific Health

2:30 PM
Multiple Myeloma‍ ‍

Tim Schmidt, MD | University of Wisconsin

3:00 PM
Melanoma
Nina Mathew, MD | Kansas University Medical Center

3:30 PM
Gynecological Oncology
John Chan, MD | California Pacific Medical Center

4:00 PM
ADJOURN

4:30 PM
Networking Activity - Star of Honolulu Dinner Cruise

Sunday, June 28, 2026

7:30 AM
Coffee and Exhibits

8:00 AM
Program Chair Welcome
Teruo Yamauchi, MD | University of Hawai'i Cancer Center (Program Chair)

Naoto Ueno, MD, PhD | University of Hawai'i Cancer Center (Program Chair)

8:10 AM
Small Cell Lung Cancer
Kyle Concannon, MD | University of Colorado

8:40 AM
Non-Small Cell Lung Cancer
Lori Pai, MD, DMD, MPH | Hawai’i Pacific Health

9:10 AM
Breakfast and Exhibits

9:25 AM
Non-CME Breakfast - Regeneron - Immunotherapy In Practice: A Compelling Case-Based Discussion Examining Actual Patients with Advanced NSCLC*

Clifton Layman, DO | Nexus Health

10:10 AM
Sarcomas and Rare Cancers
Shane Y. Morita MD, MBA, PhD, FACS, FSSO | The Queens Medical Center

10:40 AM
Panel: Updates from Japan

Yukinori Ozaki, MD | JFCR
Akihiko Shimomura, MD, PhD | National Center for Global Health and Medicine


11:10 AM
Lunch and Exhibits

11:25 AM
Non-CME Lunch - Pfizer Breast - Treatment Considerations for Patients With HR+/HER2- mBC
Sonya Reid MD, MPH | Vanderbilt University Medical Center ‍ ‍

12:10 PM
Survivorship

Valerie Ferguson, NP | Hawai’i Pacific Health

12:30 PM
AI in Oncology
Russell K Pachynski, MD | Washington University School of Medicine

12:50 PM
Early-Stage Breast Cancer
Gregory Vidal, MD, PhD | West Clinic

1:20 PM
Metastatic Breast Cancer

Akihiko Shimomura, MD, PhD | National Center for Global Health and Medicine

1:50 PM
Adjourn

Agenda Subject To Change. All times are HST.

 
 
Previous
Previous
June 27

2026 Best of ASCO® Washington DC

Next
Next
July 9

2026 Cancer Updates from Major Oncology Meetings Michigan